Polymeric micelles for parenteral delivery of curcumin: Preparation, characterization and in vitro evaluation

Colloids and Surfaces A: Physicochemical and Engineering Aspects

Volumn 390, Issue 1-3, 2011, Pages 25-32

  Song, Lei ^a   Shen, Yuanyuan ^a   Hou, Jingwen ^a   Lei, Lei ^a   Guo, Shengrong ^a   Qian, Changyun ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Crystallinity; Curcumin; Degradation; Lyophilization; Methoxypoly(ethylene glycol) b poly(e open caprolactone co p dioxanone); Micelles

Indexed keywords

COPOLYMERIZATION; COPOLYMERS; DEGRADATION; DISEASES; ENCAPSULATION; ETHYLENE; ETHYLENE GLYCOL; GEL PERMEATION CHROMATOGRAPHY; MOTION PICTURE EXPERTS GROUP STANDARDS; PLASTIC PRODUCTS; SIZE EXCLUSION CHROMATOGRAPHY; SOLUBILITY;

AMPHIPHILICS; ANTICANCER DRUG; COPOLYMER COMPOSITIONS; COPOLYMER MICELLES; CRYSTALLINITIES; CURCUMIN; CYTOTOXICITY ASSAYS; DOSE-DEPENDENT MANNER; ENCAPSULATION EFFICIENCY; HUMAN PROSTATE CANCER CELLS; HYDROLYTIC DEGRADATION; IN-VITRO; IN-VITRO EVALUATION; LYOPHILIZATION; METHOXYPOLY(ETHYLENE GLYCOL)-B-POLY(E{OPEN}-CAPROLACTONE-CO-P-DIOXANONE); MONODISPERSE; POLYMERIC MICELLE; ROOM TEMPERATURE; SMALL PARTICLE SIZE; SOLID DISPERSION; TEST RESULTS; WATER SOLUBILITIES; XRD PATTERNS;

MICELLES;

COPOLYMER; CURCUMIN; METHOXYPOLY(ETHYLENE GLYCOL) B POLY(EPSILON CAPROLACTONE CO 4 DIOXANONE); POLYCAPROLACTONE; POLYDIOXANONE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER INHIBITION; CONTROLLED STUDY; CRYSTAL STRUCTURE; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SCREENING; DRUG STABILITY; ENCAPSULATION; FREEZE DRYING; HUMAN; HUMAN CELL; MALE; MICELLE; MOLECULAR WEIGHT; PARTICLE SIZE; POLYMERIZATION; PRIORITY JOURNAL; PROSTATE CANCER; SOLUBILITY;

EID: 80855139555     PISSN: 09277757     EISSN: 18734359     Source Type: Journal    
DOI: 10.1016/j.colsurfa.2011.08.031     Document Type: Article

References (31)

1. Aggarwal B.B., Kumar A., Bharti A.C. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 2003, 23:363-398.
2. Maheshwari R.K., Singh A.K., Gaddipati J., Srimal R.C. Multiple biological activities of curcumin: a short review. Life Sci. 2006, 78:2081-2087.
3. Ma Z.S., Haddadi A., Molavi O., Lavasanifar A., Lai R., Samuel J. Micelles of poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin. J. Biomed. Mater. Res.: Part A 2008, 86A:300-310.
4. Chendil D., Ranga R.S., Meigooni D., Sathishkumar S., Ahmed M.M. Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene 2004, 23:1599-1607.
5. Barry J., Fritz M., Brender J.R., Smith P.E.S., Lee D.K., Ramamoorthy A. Determining the effects of lipophilic drugs on membrane structure by solid-state NMR spectroscopy: the case of the antioxidant curcumin. J. Am. Chem. Soc. 2009, 131:4490-4498.
6. Sun D.M., Zhuang X.Y., Xiang X.Y., Liu Y.L., Zhang S.Y., Liu C.R., Barnes S., Grizzle W., Miller D., Zhang H.G. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol. Ther. 2010, 18:1606-1614.
7. Cheng A.L., Hsu C.H., Lin J.K., Hsu M.M., Ho Y.F., Shen T.S., Ko J.Y., Lin J.T., Lin B.R., Wu M.S., Yu H.S., Jee S.H., Chen G.S., Chen T.M., Chen C.A., Lai M.K., Pu Y.S., Pan M.H., Wang Y.J., Tsai C.C., Hsieh C.Y. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001, 21:2895-2900.
8. Lao C.D., Ruffin M.T., Normolle D., Heath D.D., Murray S.I., Bailey J.M., Boggs M.E., Crowell J., Rock C.L., Brenner D.E. Dose escalation of a curcuminoid formulation. BMC Complement. Altern. Med. 2006, 6:10.
9. Anand P., Kunnumakkara A.B., Newman R.A., Aggarwal B.B. Bioavailability of curcumin: problems and promises. Mol. Pharm. 2007, 4:807-818.
10. Wang Y.J., Pan M.H., Cheng A.L., Lin L.I., Ho Y.S., Hsieh C.Y., Lin J.K. Stability of curcumin in buffer solutions and characterization of its degradation products. J. Pharm. Biomed. Anal. 1997, 15:1867-1876.
11. Tang H.D., Murphy C.J., Zhang B., Shen Y.Q., Van Kirk E.A., Murdoch W.J., Radosz M. Curcumin polymers as anticancer conjugates. Biomaterials 2010, 31:7139-7149.
12. Danquah M., Fujiwara T., Mahato R.I. Self-assembling methoxypoly(ethylene glycol)-b-poly(carbonate-co-l-lactide) block copolymers for drug delivery. Biomaterials 2010, 31:2358-2370.
13. Trivedi R., Kompella U.B. Nanomicellar formulations for sustained drug delivery: strategies and underlying principles. Nanomedicine 2010, 5:485-505.
14. Zhang X.C., Jackson J.K., Burt H.M. Development of amphiphilic diblock copolymers as micellar carriers of taxol. Int. J. Pharm. 1996, 132:195-206.
15. Allen C., Han J.N., Yu Y.S., Maysinger D., Eisenberg A. Polycaprolactone-b-poly(ethylene oxide) copolymer micelles as a delivery vehicle for dihydrotestosterone. J. Control. Release 2000, 63:275-286.
16. Richter A., Olbrich C., Krause M., Kissel T. Solubilization of Sagopilone, a poorly water-soluble anticancer drug, using polymeric micelles for parenteral delivery. Int. J. Pharm. 2010, 389:244-253.
17. Yoo H.S., Park T.G. Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer. J. Control. Release 2001, 70:63-70.
18. Letchford K., Liggins R., Burt H. Pharmaceutics, preformulation and drug delivery. J. Pharm. Sci. 2008, 97:1179-1190.
19. Mohanty C., Acharya S., Mohanty A.K., Dilnawaz F., Sahoo S.K. Curcumin-encapsulated MePEG/PCL diblock copolymeric micelles: a novel controlled delivery vehicle for cancer therapy. Nanomedicine 2010, 5:433-449.
20. Li S.M., Chen X.H., Gross R.A., McCarthy S.P. Hydrolytic degradation of PCL/PEO copolymers in alkaline media. J. Mater. Sci.: Mater. Med. 2000, 11:227-233.
21. Kim M.S., Hyun H., Khang G., Lee H.B. Preparation of thermosensitive diblock copolymers consisting of MPEG and polyesters. Macromolecules 2006, 39:3099-3102.
22. Richter A., Olbrich C., Krause M., Hoffmann J., Kissel T. Polymeric Micelles for parenteral delivery of Sagopilone: Physicochemical characterization, novel formulation approaches and their toxicity assessment in vitro as well as in vivo. Eur. J. Pharm. Biopharm. 2010, 75:80-89.
23. Jiang Z.Z., Azim H., Gross R.A., Focarete M.L., Scandola M. Lipase-catalyzed copolymerization of omega-pentadecalactone with p-dioxanone and characterization of copolymer thermal and crystalline properties. Biomacromolecules 2007, 8:2262-2269.
24. Albuerne J., Marquez L., Muller A.J., Raquez J.M., Degee P., Dubois P. Hydrolytic degradation of double crystalline PPDX-b-PCL diblock copolymers. Macromol. Chem. Phys. 2005, 206:903-914.
25. Kim S.C., Kim D.W., Shim Y.H., Bang J.S., Oh H.S., Kim S.W., Seo M.H. In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. J. Control. Release 2001, 72:191-202.
26. Shen C., Guo S., Lu C. Degradation behaviors of monomethoxy poly(ethylene glycol)-b-poly(e{open}-caprolactone) nanoparticles in aqueous solution. Polym. Adv. Technol. 2008, 19:66-72.
27. Wilhelm M., Zhao C.L., Wang Y., Xu R., Winnik M.A., Mura J.L., Riess G., Croucher M.D. Poly(styrene-ethylene oxide) block copolymer micelle formation in water: a fluorescence probe study. Macromolecules 1991, 24:1033-1040.
28. Bahadur K.C.R., Bhattarai S.R., Aryal S., Khil M.S., Dharmaraj N., Kim H.Y. Novel amphiphilic triblock copolymer based on PPDO, PCL, and PEG: Synthesis, characterization, and aqueous dispersion. Colloid Surf. A: Physicochem. Eng. Aspect 2007, 292:69-78.
29. Gaucher G., Dufresne M.H., Sant V.P., Kang N., Maysinger D., Leroux J.C. Block copolymer micelles: preparation, characterization and application in drug delivery. J. Control. Release 2005, 109:169-188.
30. Liu J., Lee H., Allen C. Formulation of drugs in block copolymer micelles: drug loading and release. Curr. Pharm. Des. 2006, 12:4685-4701.
31. Gou M.L., Zheng X.L., Men K., Zhang J., Wang B.L., Lv L., Wang X.H., Zhao Y.L., Luo F., Chen L.J., Zhao X., Wei Y.Q., Qian Z.Y. Self-assembled hydrophobic honokiol loaded MPEG-PCL diblock copolymer micelles. Pharm. Res. 2009, 26:2164-2173.